HOMA-IR与松田指数作为自身抗体阳性亲属进展为1型糖尿病的预测指标
研究纳入TrialNet Pathway to Prevention中6256例自身抗体阳性1型糖尿病亲属,评估HOMA-IR和松田指数与1型糖尿病分期进展的关联。调整胰岛素分泌指标后,从1期进展至2期及进展至3期与较高HOMA-IR和较低松田指数相关。
要点
- 调整Index60后,1期进展至2期与较高HOMA-IR(HR=1.71)和较低松田指数(HR=0.40)相关。
- 调整Index60后,1期或2期进展至3期与较高HOMA-IR(HR=1.98)和较低松田指数(HR=0.46)相关。
- 未调整时进展至3期的关联方向与调整后相反,提示胰岛素分泌指标有助于解读关联。
核心结论
- 调整胰岛素分泌指标后,进展至1型糖尿病2期和3期随HOMA-IR升高而增加、随松田指数升高而减少。
- 胰岛素分泌指标似乎有助于解读自身抗体阳性亲属中HOMA-IR或松田指数与1型糖尿病进展的关联。
研究设计与样本
- 研究纳入TrialNet Pathway to Prevention中6256例自身抗体阳性1型糖尿病患者的亲属。
- 采用Cox回归评估HOMA-IR和松田指数三分位数对分期转变的预测作用。
主要发现
- HOMA-IR(正相关)和松田指数(负相关)与基线年龄及BMI百分位强烈相关(p<0.0001)。
- 调整Index60后,从1期进展至2期与较高HOMA-IR(HR=1.71,p<0.0001)和较低松田指数(HR=0.40,p<0.0001)相关。
- 调整Index60后,从1期或2期进展至3期与较高HOMA-IR(HR=1.98,p<0.0001)和较低松田指数(HR=0.46,p<0.0001)相关。
- 未调整时,进展至3期与HOMA-IR呈负相关、与松田指数呈正相关,方向与调整后相反。
- 以IGI替代Index60时,结果相似。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIM/HYPOTHESIS: We assessed whether HOMA-IR and the Matsuda Index are associated with transitions through stages of type 1 diabetes. METHODS: Autoantibody (AAb)-positive relatives of individuals with type 1 diabetes (n=6256) from the TrialNet Pathway to Prevention were studied. Associations of indicators of insulin resistance (HOMA-IR) and insulin sensitivity (Matsuda Index) with BMI percentile (BMIp) and age were assessed with adjustments for measures of insulin secretion, Index60 and insulinogenic index (IGI). Cox regression was used to determine if tertiles of HOMA-IR and Matsuda Index predicted transitions from Not Staged (<2 AAbs) to Stage 1 (≥2 AAbs and normoglycaemia), from Stage 1 to Stage 2 (≥2 AAbs with dysglycaemia), and progression to Stage 3 (diabetes as defined by WHO/ADA criteria). RESULTS: There were strong associations of HOMA-IR (positive) and Matsuda Index (inverse) with baseline age and BMIp (p<0.0001). After adjustments for Index60, transitioning from Stage 1 to Stage 2 was associated with higher HOMA-IR and lower Matsuda Index (HOMA-IR: HR=1.71, p<0.0001; Matsuda Index, HR=0.40, p<0.0001), as with progressing from Stages 1 or 2 to Stage 3 (HOMA-IR: HR=1.98, p<0.0001; Matsuda Index: HR=0.46, p<0.0001). Without adjustments, associations of progression to Stage 3 were inverse for HOMA-IR and positive for Matsuda Index, opposite in directionality with adjustments. When IGI was used in place of Index60, the findings were similar. CONCLUSIONS/INTERPRETATION: Progression to Stages 2 and 3 of type 1 diabetes increases with HOMA-IR and decreases with the Matsuda Index after adjustments for insulin secretion. Indicators of insulin secretion appear helpful for interpreting associations of progression to type 1 diabetes with HOMA-IR or the Matsuda Index in AAb-positive relatives.
引用
- Petrelli A, Cugnata F, Carnovale D, et al. HOMA-IR and the Matsuda Index as predictors of progression to type 1 diabetes in autoantibody-positive relatives. Diabetologia. 2023. PMID: 37914981. doi:10.1007/s00125-023-06034-y
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。